New phenothiazine-type multidrug resistance modifiers: Anti-MDR activity versus membrane perturbing potency

Biochemical and Biophysical Research Communications

Volumn 304, Issue 2, 2003, Pages 260-265

  Hendrich, Andrzej B ^a   Wesołowska, Olga ^a   Motohashi, Noboru ^b   Molnár, Joseph ^c   Michalak, Krystyna ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

^c UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Drug lipid interactions; Lipid bilayer fluidity; Multidrug resistance reversal; P glycoprotein; Phenothiazine derivatives

Indexed keywords

GLYCOPROTEIN P; PHENOTHIAZINE DERIVATIVE;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG POTENCY; FLOW CYTOMETRY; FLUORESCENCE SPECTROSCOPY; HYDROPHOBICITY; LIPID BILAYER; MICROCALORIMETRY; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL;

EID: 0344088435     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)00580-1     Document Type: Article

References (39)

1. Ferte J. Analysis of the tangled relationships between P-glycoprotein-mediated multidrug resistance and the lipid phase of the cell membrane. Eur. J. Biochem. 267:2000;277-294.
2. Bosch I., Croop J. P-Glycoprotein multidrug resistance and cancer. Biochim. Biophys. Acta. 1288:1996;F37-F54.
3. Litman T., Druley T.E., Stein W.D., Bates S.E. From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance. Cell. Mol. Life Sci. 58:2001;931-959.
4. Zamora J.M., Pearce H.L., Beck W.T. Physical-chemical properties shared by compounds that modulate multidrug resistance in human leukemic cells. Mol. Pharmacol. 33:1988;454-462.
5. Klopman G., Shi L.M., Ramu A. Quantitative structure-activity relationship of multidrug resistance reversal agents. Mol. Pharmacol. 52:1997;323-334.
6. Ecker G., Huber M., Schmid D., Chiba P. The importance of a nitrogen atom in modulators of multidrug resistance. Mol. Pharmacol. 56:1999;791-796.
7. Seelig A. A general pattern for substrate recognition by P-glycoprotein. Eur. J. Biochem. 251:1998;252-261.
8. Seelig A., Landwojtowicz E. Structure-activity relationship of P-glycoprotein substrates and modifiers. Eur. J. Pharmaceut. Sci. 12:2000;31-40.
9. Wadkins R.M., Houghton P.J. The role of drug-lipid interactions in the biological activity of modulators of multi-drug resistance. Biochim. Biophys. Acta. 1153:1993;225-236.
10. Castaing M., Brouant P., Loiseau A., Santelli-Rouvier C., Santelli M., Alibert-Franco S., Mahamoud A., Barbe J. Membrane permeation by multidrug-resistance-modulators and non-modulators: effects of hydrophobicity and electric charge. J. Pharm. Pharmacol. 52:2000;289-296.
11. Eytan G.D., Regev R., Oren G., Assaraf Y.G. The role of passive transbilayer drug movement in multidrug resistance and its modulation. J. Biol. Chem. 271:1996;12897-12902.
12. Tsuruo T., Iida H., Tsukagoshi S., Sakurai Y. Increased accumulation of vincristine and adriamycin in drug-resistant P388 tumor cells following incubation with calcium antagonists and calmodulin inhibitors. Cancer Res. 42:1982;4730-4733.
13. Molnár J., Hever A., Fakla I., Ocsovski I., Aszalos A. Inhibition of the transport function of membrane proteins by some substituted phenothiazines in E. coli and multidrug resistant tumor cells. Anticancer Res. 17:1997;481-486.
14. Molnár J., Szabo D., Mándi Y., Mucsi I., Fischer J., Varga A., König S., Motohashi N. Multidrug resistance reversal in mouse lymphoma cells by heterocyclic compounds. Anticancer Res. 18:1998;3033-3038.
15. 31 P NMR studies on the interaction of some phenothiazine derivatives with dipalmitoyl phosphatidylcholine model membranes Biochim. Biophys. Acta. 507:1978;185-197.
16. Hanpft R., Mohr K. Influence of cationic amphiphilic drugs on the phase-transition temperature of phospholipids with different polar headgroups. Biochim. Biophys. Acta. 814:1985;156-162.
17. Hendrich A.B., Wesołowska O., Michalak K. Differences and similarities in the influence of trifluoperazine on the phase transitions of phosphatidylcholine and hosphatidylethanolamine. Curr. Topics Biophys. 25:2001;67-69.
18. Wesołowska O., Hendrich A.B., Motohashi N., Michalak K. Phenothiazine derivative causes phase separation in phosphatidylethanolamine model membranes. Curr. Topics Biophys. 25:2001;71-73.
19. Hendrich A.B., Wesołowska O., Komorowska M., Motohashi N., Michalak K. The alterations of lipid bilayer fluidity induced by newly synthesized phenothiazine derivative. Biophys. Chem. 98:2002;275-285.
20. Isomaa B., Hägerstrand H., Paatero G. Shape transformations induced by amphiphiles in erythrocytes. Biochim. Biophys. Acta. 899:1987;93-103.
21. Rosso J., Zachowski A., Devaux P.F. Influence of chorpromazine on the transverse mobility of phospholipids in human erythrocyte membrane: relation to shape changes. Biochim. Biophys. Acta. 942:1988;271-279.
22. Malheiros S.V., de Paula E., Meirelles N.C. Contribution of trifluoperazine/lipid ratio and drug ionization to hemolysis. Biochim. Biophys. Acta. 1373:1998;332-340.
23. 13 C-NMR and differential scanning calorimetry Biochim. Biophys. Acta. 1464:2000;165-175.
24. Hendrich A.B., Wesołowska O., Michalak K. Trifluoperazine induces domain formation in zwitterionic phosphatidylcholine but not in charged phosphatidylglycerol bilayers. Biochim. Biophys. Acta. 1510:2001;414-425.
25. Ford J.M., Prozialeck W.C., Hait W.N. Structural features determining activity of phenothiazines and related drugs for inhibition of cell growth and reversal of multidrug resistance. Mol. Pharmacol. 35:1989;105-115.
26. Ramu A., Ramu N. Reversal of multidrug resistance by phenothiazines and structurally related compounds. Cancer Chemother. Pharmacol. 30:1992;165-173.
27. Pajeva I.K., Wiese M., Cordes H.P., Seydel J.K. Membrane interactions of some catamphilic drugs and relation to their multidrug-resistance-reversing ability. J. Cancer Res. Clin. Oncol. 122:1996;27-40.
28. Pajeva I.K., Wiese M. QSAR and molecular modelling of catamphilic drugs able to modulate multidrug resistance in tumors. Quant. Struct.-Act. Relat. 16:1997;1-10.
29. Motohashi N., Kawase M., Saito S., Kurihara T., Satoh K., Nakashima H., Premanathan M., Arakaki R., Sakagami H., Molnar J. Synthesis and biological activity of N-acylphenothiazines. Int. J. Antimicrob. Agents. 14:2000;203-207.
30. N. Motohashi, M. Kawase, J. Molnar, L. Ferenczy, O. Wesolowska, A.B. Hendrich, M. Bobrowska-Hagerstrand, H. Hagerstrand, K. Michalak, Antimicrobial activity of N-acylphenothiazines and their influence on lipid model membranes and erythrocyte membranes, Arzneim-Forsch (in press).
31. Ghose A.K., Pritchett A., Crippen G.M. Atomic physicochemical parameters for three dimensional structure activity relationships III: modelling hydrophobic interactions. J. Comput. Chem. 9:1988;80-90.
32. 2(3) is not a substrate for multidrug resistance protein (MRP)-mediated drug efflux Cytometry. 25:1996;14-20.
33. Bosch I., Crankshaw C.L., Piwnica-Worms D., Croop J.M. Characterization of functional assays of multidrug resistance P-glycoprotein transport activity. Leukemia. 11:1997;1131-1137.
34. Pastan I., Gottesman M.M., Ueda K., Lovelace E., Rutheford A.V., Willingham M.C. A retrovirus carrying an MDR-1 cDNA confers multidrug resistance and polarized expression of P-glycoprotein in MDCK cells. Proc. Natl Acad. Sci. USA. 85:1988;4486-4490.
35. Weaver J.L., Szabo G., Pine P.S., Gottesman M.M., Goldenberg S., Aszalos A. The effect of ion channel blockers, immunosupressive agents, and other drugs on the activity of the multi-drug transporter. Int. J. Cancer. 54:1993;456-461.
36. Kaiser R.D., London E. Location of diphenylhexatriene (DPH) and its derivatives within membranes: comparison of different fluorescence quenching analyses of membrane depth. Biochemistry. 37:1998;8180-8190.
37. Matayoshi E.D., Kleinfeld A.M. Emission-wavelength-dependent decay of the fluorescent probe N-phenyl-1-naphthylamine. Biochim. Biophys. Acta. 644:1981;233-243.
38. Liu R., Sharom F.J. Site-directed fluorescence labeling of P-glycoprotein on cysteine residues in the nucleotide binding domains. Biochemistry. 35:1996;11865-11873.
39. Liu R., Siemiarczuk A., Sharom F.J. Intrinsic fluorescence of the P-glycoprotein multidrug transporter: sensitivity of tryptophan residues to binding of drugs and nucleotides. Biochemistry. 39:2000;14927-14938.